LAABKYV Trademark

Trademark Overview

On Tuesday, May 21, 2024, a trademark application was filed for LAABKYV with the United States Patent and Trademark Office. The USPTO has given the LAABKYV trademark a serial number of 79398679. The federal status of this trademark filing is REGISTERED as of Tuesday, May 20, 2025. This trademark is owned by AstraZeneca UK Limited. The LAABKYV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, namely antibodies for neutralizing viruses for medical purposes
laabkyv

General Information

Serial Number79398679
Word MarkLAABKYV
Filing DateTuesday, May 21, 2024
Status700 - REGISTERED
Status DateTuesday, May 20, 2025
Registration Number7797614
Registration DateTuesday, May 20, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances, namely antibodies for neutralizing viruses for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 27, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca UK Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameAstraZeneca UK Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameAstraZeneca UK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, June 27, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, July 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 3, 2024APPLICATION FILING RECEIPT MAILED
Monday, September 16, 2024ASSIGNED TO EXAMINER
Friday, September 20, 2024NON-FINAL ACTION WRITTEN
Saturday, September 21, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 24, 2024REFUSAL PROCESSED BY MPU
Wednesday, September 25, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 12, 2024REFUSAL PROCESSED BY IB
Monday, January 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 7, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 20, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 20, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 20, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, November 26, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 26, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, December 11, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, December 19, 2025FINAL DISPOSITION PROCESSED
Friday, December 19, 2025FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 8, 2026FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

laabkyv viruses medical purposes neutralizing antibodies preparations substances namely pharmaceutical